BGLC 8-K 2026-10-07

BioNexus Gene Lab Corp (BGLC) 8-K dated 2026-10-07 — accession 0001477932-26-006075. This URL is the filing, not the BGLC hub.

BioNexus Gene Lab Corp (BGLC) is a specialty chemicals company listed on NASDAQ.

BioNexus Gene Lab Corp filed a 8-K on 2026-10-07. Accession 0001477932-26-006075.

Cached items: 1.01, 3.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported BGLC revenue for 2025-12-31 was $7.4M. Net income was -$3.0M. Revenue was down 21.9% from 2024-12-31 to 2025-12-31. BGLC currently screens at market cap $6.1M.

Not investment advice. The BGLC SEC hub lists recent forms. The stock page is the research view.